Innovating and Serving the Poor with Antiretroviral Drug Systems: Advances in the HIV Brazilian Program

Maria Matilde Zraik Baracat (Federal University of Parana, Brazil) and Farley Simon Nobre (Federal University of Parana, Brazil)
Copyright: © 2013 |Pages: 19
EISBN13: 9781466641181|DOI: 10.4018/978-1-4666-2842-7.ch001
OnDemand PDF Download:
$30.00
List Price: $37.50
OnDemand PDF Download
Download link provided immediately after order completion
$30.00
List Price: $37.50
Current Promotions:
Take 20% Off All Publications Purchased Directly Through the IGI Global Online Bookstore: www.igi-global.com/

Abstract

This chapter presents an exploratory study about the Brazilian program on Human Immunodeficiency Virus (HIV). It highlights the social and technological contributions, which have resulted from the production of antiretroviral drugs by the pharmaceutical industry in Brazil. First, this chapter reviews literature on the history of HIV epidemic and presents the HIV context as a pathology that affects the health of countries, putting at risk their economic and social development. Second, it analyzes the current situation of this epidemic in Brazil, by characterizing the Brazilian Pharmaceutical Industry (BPI). Third, this chapter elucidates the Brazilian production of antiretroviral drugs mainly based on aspects of patent law and Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Results show that the adoption of the Brazilian program for HIV has been successful and encouraged its diffusion to, and adoption by, other countries due to its capability for wide and unrestricted distribution of medicines.
InfoSci-OnDemand Powered Search